Howland Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,531
| Closed | -$231K | – | 271 |
|
|
2025
Q4 | $231K | Sell |
4,531
-878
| -16% | -$44.9K | 0.01% | 255 |
|
|
2025
Q3 | $300K | Buy |
5,409
+1,236
| +30% | +$72.3K | 0.01% | 240 |
|
|
2025
Q2 | $288K | Buy |
4,173
+128
| +3% | +$8.71K | 0.01% | 238 |
|
|
2025
Q1 | $286K | Sell |
4,045
-2,351
| -37% | -$194K | 0.01% | 240 |
|
|
2024
Q4 | $550K | Sell |
6,396
-49
| -0.8% | -$5.3K | 0.02% | 200 |
|
|
2024
Q3 | $767K | Sell |
6,445
-1,585
| -20% | -$211K | 0.03% | 169 |
|
|
2024
Q2 | $1.15M | Hold |
8,030
| – | – | 0.05% | 133 |
|
|
2024
Q1 | $1.04M | Sell |
8,030
-716
| -8% | -$85.2K | 0.05% | 133 |
|
|
2023
Q4 | $905K | Hold |
8,746
| – | – | 0.05% | 138 |
|
|
2023
Q3 | $795K | Buy |
8,746
+5,000
| +133% | +$440K | 0.05% | 142 |
|
|
2023
Q2 | $303K | Sell |
3,746
-200
| -5% | -$16.3K | 0.02% | 216 |
|
|
2023
Q1 | $317K | Sell |
3,946
-858
| -18% | -$60.8K | 0.02% | 218 |
|
|
2022
Q4 | $325K | Hold |
4,804
| – | – | 0.02% | 205 |
|
|
2022
Q3 | $239K | Hold |
4,804
| – | – | 0.02% | 220 |
|
|
2022
Q2 | $268K | Hold |
4,804
| – | – | 0.02% | 213 |
|
|
2022
Q1 | $267K | Buy |
4,804
+400
| +9% | +$20.5K | 0.01% | 197 |
|
|
2021
Q4 | $247K | Buy |
4,404
+104
| +2% | +$5.63K | 0.01% | 212 |
|
|
2021
Q3 | $206K | Buy |
+4,300
| New | +$208K | 0.01% | 233 |
|
|
2019
Q2 | – | Sell |
-11,400
| Closed | -$298K | – | 204 |
|
|
2019
Q1 | $298K | Buy |
11,400
+1,400
| +14% | +$34.4K | 0.02% | 171 |
|
|
2018
Q4 | $230K | Hold |
10,000
| – | – | 0.02% | 185 |
|
|
2018
Q3 | $236K | Hold |
10,000
| – | – | 0.02% | 204 |
|
|
2018
Q2 | $231K | Hold |
10,000
| – | – | 0.02% | 207 |
|
|
2018
Q1 | $246K | Sell |
10,000
-5,500
| -35% | -$144K | 0.02% | 200 |
|
|
2017
Q4 | $416K | Hold |
15,500
| – | – | 0.03% | 167 |
|
|
2017
Q3 | $373K | Hold |
15,500
| – | – | 0.03% | 175 |
|
|
2017
Q2 | $332K | Hold |
15,500
| – | – | 0.03% | 179 |
|
|
2017
Q1 | $266K | Buy |
+15,500
| New | +$270K | 0.02% | 191 |
|
|
2016
Q4 | – | Sell |
-10,000
| Closed | -$208K | – | 217 |
|
|
2016
Q3 | $208K | Hold |
10,000
| – | – | 0.02% | 196 |
|
|
2016
Q2 | $269K | Hold |
10,000
| – | – | 0.03% | 172 |
|
|
2016
Q1 | $271K | Hold |
10,000
| – | – | 0.03% | 176 |
|
|
2015
Q4 | $290K | Hold |
10,000
| – | – | 0.03% | 173 |
|
|
2015
Q3 | $271K | Hold |
10,000
| – | – | 0.03% | 172 |
|
|
2015
Q2 | $274K | Hold |
10,000
| – | – | 0.03% | 173 |
|
|
2015
Q1 | $267K | Buy |
+10,000
| New | +$230K | 0.03% | 174 |
|
Other funds holding NVO
DAM
F
Howland Capital Management's NVO Position: Q1 2026 in Review
Howland Capital Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,531 shares — an estimated $231K sold.
Howland Capital Management first reported a position in NVO in Q1 2015 and held it in 34 quarters. The position peaked at $1.15M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Howland Capital Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Howland Capital Management sold 4,531 Novo Nordisk shares in Q1 2026, an estimated $231K.
- Howland Capital Management first reported a position in Novo Nordisk in Q1 2015 and held it in 34 quarters.
- Howland Capital Management's Novo Nordisk position peaked at $1.15M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Howland Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.